KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Cash & Equivalents (2016 - 2026)

Johnson & Johnson's Cash & Equivalents history spans 18 years, with the latest figure at $21.7 billion for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 43.63% to $21.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $21.7 billion, a 43.63% decrease, with the full-year FY2025 number at $19.7 billion, down 18.24% from a year prior.
  • Cash & Equivalents hit $21.7 billion in Q1 2026 for Johnson & Johnson, up from $19.7 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for JNJ hit a ceiling of $38.5 billion in Q1 2025 and a floor of $10.5 billion in Q2 2022.
  • Historically, Cash & Equivalents has averaged $19.6 billion across 5 years, with a median of $19.7 billion in 2023.
  • Biggest five-year swings in Cash & Equivalents: soared 92.87% in 2023 and later tumbled 43.63% in 2026.
  • Tracing JNJ's Cash & Equivalents over 5 years: stood at $11.4 billion in 2022, then skyrocketed by 92.51% to $21.9 billion in 2023, then rose by 10.27% to $24.1 billion in 2024, then dropped by 18.24% to $19.7 billion in 2025, then rose by 10.04% to $21.7 billion in 2026.
  • Business Quant data shows Cash & Equivalents for JNJ at $21.7 billion in Q1 2026, $19.7 billion in Q4 2025, and $18.2 billion in Q3 2025.